Benzinga - U.S. stocks traded mixed, with the Dow Jones dropping around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
- Geron Corporation (NASDAQ: GERN) shares climbed 53.3% to $3.6800 after the company announced top-line results from the IMerge Phase 3 trial of imetelstat in lower risk MDS. The trial met the primary 8-week transfusion independence (TI) endpoint and key secondary 24-week TI endpoint.
- Dada Nexus Limited (NASDAQ: DADA) rose 18.4% to $10.45. Shares of Chinese companies traded higher after Chinese regulators reportedly approved a capital raise for Ant Group.
- NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) gained 17.7% to $12.36.
- Baozun Inc. (NASDAQ: BZUN) surged 15.3% to $6.50.
- I-Mab (NASDAQ: IMAB) gained 15% to $4.88.
- Futu Holdings Limited (NASDAQ: FUTU) jumped 13.8% to $43.07. Shares of Chinese companies traded higher after Chinese regulators reportedly approved a capital raise for Ant Group.
- GDS Holdings Limited (NYSE: GDS) gained 13.8% to $27.00. Shares of Chinese companies traded higher after Chinese regulators reportedly approved a capital raise for Ant Group.
- Kingsoft Cloud Holdings Limited (NASDAQ: KC) gained 13.2% to $4.46. Kingsoft Cloud Holdings recently successfully listed on Hong Kong Stock Exchange. Shares of Chinese companies traded higher after Chinese regulators reportedly approved a capital raise for Ant Group.
- Poseida Therapeutics, Inc. (NASDAQ: PSTX) gained 13% to $6.54. HC Wainwright & Co. initiated coverage on Poseida Therapeutics with a Buy rating and announced a price target of $15.
- Altus Power, Inc. (NASDAQ: AMPS) jumped 12.6% to $6.98. Evercore ISI Group initiated coverage on Altus Power with an Outperform rating and announced a price target of $15.
- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) gained 12.3% to $17.90. Deciphera Pharmaceuticals announced an exploratory analysis of data from the INTRIGUE Phase 3 study of Qinlock using circulating tumor DNA (ctDNA).
- LexinFintech Holdings Ltd. (NASDAQ: LX) jumped 11.9% to $2.2050.
- Oatly Group (NASDAQ:OTLY) AB (NASDAQ: OTLY) gained 11.4% to $2.2409. Oatly Group announced a long-term strategic hybrid partnership with Ya YA Foods, in which the company will receive roughly $72 million.
- XPeng Inc. (NYSE: XPEV) jumped 10% to $11.20. Shares of Chinese companies traded higher after Chinese regulators reportedly approved a capital raise for Ant Group.
- American Well Corporation (NASDAQ: AMWL) surged 9.7% to $3.0950. B of A Securities upgraded American Well from Neutral to Buy and announced a $4.2 price target.
- Fate Therapeutics, Inc. (NASDAQ: FATE) jumped 9.5% to $11.14.
- Icosavax, Inc. (NASDAQ: ICVX) gained 9.2% to $9.06. Oppenheimer initiated coverage on Icosavax with an Outperform rating and announced a price target of $27.
- Alibaba (NYSE:BABA) Group Holding Limited (NYSE: BABA) gained 7.6% to $98.97 following reports Chinese regulators approved a capital raise for Alibaba co-founder Jack Ma's Ant Group.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.